PubMed ID:
21521847
Public Release Type:
Journal
Publication Year: 2011
Affiliation: Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University, New York, New York, USA. jl3553@columbia.edu
DOI:
https://doi.org/10.1001/jama.2011.520
Authors:
Barlow S,
Siegner J,
Hoffmann JA,
Thompson J,
Abrams SH,
Fairly LA,
Lavine JE,
Schwimmer JB,
Behling C,
Durelle J,
Rose S,
Stein T,
Bass NM,
Rosenthal P,
Ferrell LD,
Merriman R,
Pabst M,
Boyett S,
Sargeant C,
Sandhu B,
Fuchs M,
Luketic VA,
Contos MJ,
Bryan D,
Sanyal AJ,
Murray KF,
Rosenthal P,
Abrams SH,
Scheimann AO,
Sanyal AJ,
Chalasani N,
Tonascia J,
Ünalp A,
Clark JM,
Brunt EM,
Kleiner DE,
Hoofnagle JH,
Robuck PR,
Nonalcoholic Steatohepatitis Clinical Research Network,
Lavine JE,
Sanyal AJ,
Abrams SH,
Bass NM,
Chalasani N,
Diehl AM,
Kowdley KV,
Loomba R,
McCullough AJ,
Molleston JP,
Murray KF,
Robuck PR,
Rosenthal P,
Neuschwander-Tetri BA,
Tonascia J,
Lavine JE,
Schwimmer JB,
Ünalp A,
McCullough AJ,
Stager M,
Dasarathy S,
Hawkins C,
Liu YC,
Filipowski D,
Sargent R,
Whitwell J,
Diehl AM,
Abdelmalek MF,
Guy C,
Piercy D,
Smith M,
Pan YP,
Scheimann AO,
Torbenson M,
Pfeifer K,
Chalasani N,
Molleston JP,
Cummings OW,
Klipsch A,
Ragozzino L,
Subbarao G,
Vuppalanchi R,
Neuschwander-Tetri BA,
Derdoy J,
Brunt EM,
Stewart S,
Lee W,
Reboussin DM,
Buse J,
Rand E,
Jonas M,
Morgan T,
Yates KP,
Wilson LA,
Vaughn I,
Van Natta ML,
Ünalp A,
Sternberg A,
Miriel LA,
Jin WK,
Isaacson M,
Green M,
Donithan M,
Colvin R,
Clark JM,
Belt P,
Tonascia J,
Huang TT,
Robuck PR,
Hoofnagle JH,
Lavine JE,
Schwimmer JB,
Van Natta ML,
Molleston JP,
Doo EC,
Kleiner DE,
Young M,
Yeh M,
Murray KF,
Shaw C,
Ackermann S,
Nelson J,
Kowdley KV,
Nair K,
Mohan P,
Jones A,
White M
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
,
Treatment of Nonalcoholic Fatty Liver Disease in Children
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US children and adolescents and can present with advanced fibrosis or nonalcoholic steatohepatitis (NASH). No treatment has been established.